REG - Morgan Sindall Grp - Director/PDMR Shareholding

Morgan SindallAnnouncement

06/03/2025 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250306:nRSF7085Za&default-theme=true

RNS Number : 7085Z  Morgan Sindall Group PLC  06 March 2025

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations
under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

 1.  Details of Restricted Person/person closely associated with them ("PCA")
 a)  Name                                                            John Morgan (Chief Executive)

                                                                     Kelly Gangotra (Chief Financial Officer)
 2.  Reason for the notification
 a)  Position/status                                                 Members of the Board of directors
 b)  Initial notification/amendment                                  Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                            Morgan Sindall Group plc
 b)  LEI                                                             2138008339ULDGZRB345
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument     Ordinary shares of 5 pence each

     Identification code

                                                                     ISIN: GB0008085614
 b)  Nature of the transaction                                       Grant of nil cost share options on 6 March 2025, under the Company's Deferred
                                                                     Bonus Plan, adopted by the Company on 28 November 2017.  The nil cost options
                                                                     granted are equivalent to 33% of the annual bonus earned for the year ended 31
                                                                     December 2024.  Each nil cost option will mature and become exercisable from
                                                                     6 March 2028. The share price used to determine the number of nil cost options
                                                                     is £32.50.  Each nil cost option carries a right to receive, on maturity, an
                                                                     amount linked to dividends paid on the Ordinary Shares subject to the
                                                                     conditional award.  The dividend equivalent can be settled in cash or
                                                                     Ordinary shares of the Company.
 c)  Price(s) and volume(s)                                          Name            Price(s)  Volume(s)
                                                                     John Morgan     N/A       9,366
                                                                     Kelly Gangotra  N/A       4,903
 d)  Aggregated information                                          As above

     -     Aggregated volume

     -     Price
 e)  Date of the transaction                                         6 March 2025
 f)  Place of the transaction                                        Outside a trading venue

d)

Aggregated information

-     Aggregated volume

-     Price

As above

 

e)

Date of the transaction

6 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFVRVTIRIIE